Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Revelation Biosciences, Inc. (REVB) had Income from Continuous Operations of $-2.44M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.63M |
|
-- |
|
-- |
|
$2.46M |
|
$-2.46M |
|
$0.02M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
|
Income from Continuous Operations |
$-2.44M |
$-2.44M |
|
$-2.44M |
|
$-2.46M |
|
$-2.45M |
|
0.80M |
|
0.80M |
|
$-7.01 |
|
$-7.01 |
|
| Balance Sheet Financials | |
$5.36M |
|
$0.04M |
|
$0.04M |
|
$5.40M |
|
$1.57M |
|
-- |
|
-- |
|
$1.57M |
|
$3.83M |
|
$3.83M |
|
$3.83M |
|
1.53M |
|
| Cash Flow Statement Financials | |
$-4.71M |
|
-- |
|
$3.39M |
|
$6.50M |
|
$5.17M |
|
$-1.33M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-63.89% |
|
-63.89% |
|
-45.31% |
|
-63.89% |
|
$2.49 |
|
$-5.87 |
|
$-5.87 |
|